P

Palm Beach Research Center | West Palm Beach, FL

Research site

(Unclaimed)

Location

2277 Palm Beach Lakes Boulevard, West Palm Beach, Florida, United States of America

Site insights

Top conditions

Top treatments

IHL-42X

Elinzanetant

Donanemab

GRT7039

Galcanezumab

Tirzepatide

Retatrutide

LY3437943

LY3298176

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).

Enrolling

Alzheimer Disease

Drug: Donanemab

Drug: Placebo

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling

Overweight

Obesity

Drug: Placebo

Drug: Retatrutide

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause (NIRVANA)

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Enrolling

Sleep Disturbances Associated With Menopause

Other: Placebo

Drug: Elinzanetant

Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

An open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular injections of RTX-GRT7039 in...

Active, not recruiting

Osteoarthritis

Drug: RTX-GRT7039

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA (REPOSA)

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Enrolling

Obstructive Sleep Apnea

Drug: Placebo

Drug: Acetazolamide